Heart-lung transplantation: Cardiac clinicopathological correlations

Area of Science:

• Cardiology
• Thoracic Surgery
• Immunology

Background:

• Heart-lung transplantation (H-LTx) reports often focus on lung pathology.
• Cardiac pathology in H-LTx recipients requires comprehensive clinicopathological assessment.
• Understanding cardiac complications is crucial for improving H-LTx outcomes.

Purpose of the Study:

• To perform a clinicopathological assessment of cardiac pathology in H-LTx recipients.
• To compare cardiac rejection and graft coronary disease rates between H-LTx and heart transplant (HTx) alone patients.
• To analyze the impact of cardiac pathology on transplant survival and the incidence of obliterative bronchiolitis (OB).

Main Methods:

• Retrospective analysis of 75 consecutive H-LTx cases (1981-1989).
• Review of endomyocardial biopsies, autopsy findings, and clinical data.
• Comparison with 391 HTx alone cases performed during the same period.

Main Results:

• H-LTx recipients showed significantly less acute cardiac rejection (40% within 3 months) compared to HTx alone (80%) (p < .005).
• Graft coronary disease occurred less frequently in H-LTx (7.73% within 5 years) versus HTx alone (25.87%) (p < .005).
• Obliterative bronchiolitis was more prevalent in H-LTx with graft coronary disease (71.43%) than without (41.38%) (p < .05).

Conclusions:

• H-LTx recipients experience lower rates of cardiac rejection and graft coronary disease compared to HTx alone.
• Cardiac rejection in H-LTx predominantly occurs within the first 6 months post-transplant.
• The similar survival rates of H-LTx to lung transplants suggest pulmonary factors significantly influence overall H-LTx survival.